(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 790.20 | 782.30 | 609.09 | 1.0% | 29.7% |
Total Expenses | 655.60 | 620.10 | 506.53 | 5.7% | 29.4% |
Profit Before Tax | 134.60 | 162.20 | 102.57 | -17.0% | 31.2% |
Tax | 42.10 | 41.50 | 25.90 | 1.4% | 62.5% |
Profit After Tax | 92.50 | 120.70 | 76.55 | -23.4% | 20.8% |
Earnings Per Share | 2.20 | 2.70 | 9.00 | -18.5% | -75.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Krishna Institute of Medical Sciences Ltd is a prominent healthcare provider in India, specializing in delivering comprehensive medical services across various specialties. The company operates a network of hospitals that offer a wide range of healthcare services, including tertiary and quaternary care, across multiple medical disciplines. Known for its commitment to quality healthcare, Krishna Institute of Medical Sciences Ltd provides services such as cardiology, neurology, orthopedics, and oncology, among others. Recently, the company has been expanding its reach and enhancing its service offerings to cater to the growing demand for healthcare services in the region. Specific recent developments concerning strategic partnerships, technological advancements, or expansion activities are not available from the data provided.
In the third quarter of fiscal year 2025 (Q3FY25), Krishna Institute of Medical Sciences Ltd reported a total income of ₹790.20 crores. This marks a 1.0% increase from the previous quarter (Q2FY25), where total income was ₹782.30 crores. Compared to the same quarter in the previous year (Q3FY24), there is a significant year-over-year growth of 29.7% from ₹609.09 crores. The consistent increase in revenue highlights the company's ability to sustain growth over different fiscal periods. The rise in total income can be attributed to the increasing demand for healthcare services and potentially expanded service offerings or improved patient intake.
For Q3FY25, Krishna Institute of Medical Sciences Ltd reported a profit before tax of ₹134.60 crores, which reflects a decrease of 17.0% when compared to the previous quarter's ₹162.20 crores. However, on a year-over-year basis, there is a 31.2% increase from ₹102.57 crores in Q3FY24. The tax expense for Q3FY25 amounted to ₹42.10 crores, showing a slight quarter-over-quarter increase of 1.4% from ₹41.50 crores and a 62.5% increase year-over-year from ₹25.90 crores. The profit after tax for Q3FY25 was ₹92.50 crores, down by 23.4% from the previous quarter's ₹120.70 crores but up by 20.8% from ₹76.55 crores in Q3FY24. Despite the quarterly decline in profits, the year-over-year growth indicates an overarching positive trend in profitability.
The earnings per share (EPS) for Krishna Institute of Medical Sciences Ltd in Q3FY25 stood at ₹2.20, which is a decline of 18.5% from ₹2.70 in Q2FY25 and a significant decrease of 75.6% from ₹9.00 in Q3FY24. This decline reflects the decrease in quarterly profits and suggests variations in share performance compared to prior periods. The total expenses in Q3FY25 were ₹655.60 crores, which represents an increase of 5.7% from the previous quarter's ₹620.10 crores and a year-over-year increase of 29.4% from ₹506.53 crores in Q3FY24. The rise in expenses could be associated with operational scaling or increased costs associated with service provision, which have impacted the company's quarterly profitability.